Fatigue in Parkinson's disease

Bibliography

• Kroenke K, Wood DR, Mangelsdorff AD, Chronic fatigue in primary care. Prevalence, patient characteristics and outcome. JAMA 1988;260:929-34; DSM IV TR
   PubMed Web of Science ®Google Scholar
• Skapinakis P, Lewis G, Meltzer H. Clarifying the relationship between unexplained chronic fatigue and psychiatric morbidity: results from a community survey in Great Britain. Int Rev Psych 2003;15:57-64
   Google Scholar
• Maghout-Juratlis S, Janisse J, Schwartz K, The causal role of fatigue in the stress-perceived relationship: a MetroNet study. J Am Board Fam Med 2010;23:212-19
   PubMed Web of Science ®Google Scholar
• Tyne HL, Taylor J, Baker GA, Modafinil for Parkinson's disease fatigue. J Neurol 2010;257:452-6
   PubMed Web of Science ®Google Scholar
• Lou JS, Dimitrova DM, Park BS, Using modafinil to treat fatigue in Parkinson's disease: a double blind placebo controlled pilot study. Clin Neuropharm 2009;32:305-10
   PubMed Web of Science ®Google Scholar
• Ondo WG, Fayle R, Atassi F, Modafinil for daytime somnolence in Parkinson's disease: double blind placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005;76:1636-9
   PubMed Web of Science ®Google Scholar
• Mendonca D, Menezes K, Jog MS. Methylphenidate improves fatigue scores in Parkinson's disease: a randomized controlled trial. Mov Disord 2007;22:2070-6
   PubMed Web of Science ®Google Scholar
• Schifitto G, Friedman JH, Oakes D, Fatigue in levodopa-naive subjects with Parkinson's disease. Neurol 2008;71:481-5
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Martinez-Martin P, Brown RG, The Metric properties of a novel non-motor symptoms scale for Parkinson's disease: results of an international pilot study. Mov Disord 2007;22:1901-11
   PubMed Web of Science ®Google Scholar
• Chaudhuri A, Behan PO. Fatigue in neurological disorders. Lancet 2004;363:978-88
   PubMed Web of Science ®Google Scholar
• Garssen MP, Van Konningsveld R, Van Doorn PA. Residual fatigue is independent of antecedent eventrs and disease severity in Gillain-Barre syndrome. J Neurol 2006;253:1143-6
   PubMed Web of Science ®Google Scholar
• Krupp LB, LaRocca NG, Muir-Nash J, The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3
   PubMed Web of Science ®Google Scholar
• Brown RG, Dittner A, Findley L, Wessely SC. The Parkinson fatigue scale. Parkinsonism Relat Disord 2005;11:49-55
   PubMed Web of Science ®Google Scholar
• Jason LA, Evans M, Brown M, What is fatigue? Pathological and non-pathological fatigue. PMR 2010;2:327-31
   PubMedGoogle Scholar
• Friedman JH, Alves G, Hagell P, Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease. Mov Disord 2010;25:805-22
   PubMed Web of Science ®Google Scholar
• Lou JS, Kearns G, Oken B, Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 2001;16:190-6
   PubMed Web of Science ®Google Scholar
• Lou JS, Kearns G, Benice T, Levodopa improves physical fatigue in Parkinson's disease: a double-blind placebo-controlled study. Mov Disord 2003;18:1108-14
   PubMed Web of Science ®Google Scholar
• Jones DEJ, Gray JC, Newton J. Perceived fatigue is comparable between different disease groups. Q J Med 2009;102:617-24
   Google Scholar
• Smets EMA, Garssen B, Onke B, The multi-dimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25
   PubMed Web of Science ®Google Scholar
• Yellen SB, Cella DF, Webster K, Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997;13:63-74
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Schapira A, Stocchi F, Prevalence of non-motor symptoms in Parkinson's disease in an international setting; study using non-motor symptoms questioannaire in 545 patients. Mov Disord 2007;22:1623-9
   PubMed Web of Science ®Google Scholar
• Friedman JH, Brown RG, Comella C, Fatigue in Parkinson's disease. Mov Disord 2007;22:297-308
   PubMed Web of Science ®Google Scholar
• Van Hilten JJ, Hoogland G, van der Velde EA, Diurnal effects of motor activity and fatigue in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:874-7
   PubMed Web of Science ®Google Scholar
• Friedman JH, Friedman H. Fatigue in Parkinson's disease. Neurology 1993;43:2016-18
   PubMed Web of Science ®Google Scholar
• van Hilten JJ, Weggeman M, van der Velde EA, Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect 1993;5:235-44
   PubMedGoogle Scholar
• Karlsen K, Larsen JP, Tandberg E, Fatigue in patients with Parkinson's disease. Mov Disord 1999;14:237-41
   PubMed Web of Science ®Google Scholar
• Abe K, Takanashi M, Yanagihara T. Fatigue in patients with Parkinson's disease. Behav Neurol 2000;12:103-6
   PubMed Web of Science ®Google Scholar
• Goulart FO, Godke BA, Borges V, Fatigue in a cohort of geriatric Parkinson disease patients with and without fatigue. Braz J Med Biol Res 2009;42:771-5
   PubMed Web of Science ®Google Scholar
• Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, The impact of non-motor symptoms in health related quality of life of patients with Parkinson's disease. Mov Disord 2011;26(13);399-406
   PubMedGoogle Scholar
• Gallagher DA, Lees AJ, Schrag A. What are the most important non-motor symptoms in patients with Parkinson's disease? Mov Disord 2010;25:243-50
   PubMedGoogle Scholar
• Okuma Y, Kamei S, Morita A, Fatigue in Japanese patients with Parkinson's disease: a study using the Parkinson fatigue scale. Mov Disord 2009;24:1977-83
   PubMed Web of Science ®Google Scholar
• Barone P,Antonini A, Colosimo C, et al. The PRIAMO study: a multicenter assessment of non-motor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 2009;24:1641-9
   PubMed Web of Science ®Google Scholar
• Beiske AG, Loge JH, Hjermstad MJ, Fatigue in Parkinson's disease: prevalence and associated features. Mov Disord 2010;25:2456-60
   PubMed Web of Science ®Google Scholar
• Politsis M, Wu K, Molloy S, Parkinson's disease symptoms: the patient's perspective. Mov Disord 2010;25:1646-51
   PubMedGoogle Scholar
• Friedman JH, Friedman H. Fatigue in Parkinson's disease: a nine-year follow-up. Mov Disord 2001;16:1120-2
   PubMed Web of Science ®Google Scholar
• Alves G, Wentzel-Larsen T, Larsen JP. Is fatigue an independent and persistent symptom in patients with Parkinson's disease? Neurology 2004;63:1908-11
   PubMed Web of Science ®Google Scholar
• Valko PO, Waldvogel D, Weller M, Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 2010;17:1428-36
   PubMed Web of Science ®Google Scholar
• Brooks DJ. Imaging Approaches to Parkinson Disease. J Nucl Med 2010;51:596-609
   PubMed Web of Science ®Google Scholar
• Brooks DJ, Pavese N. Imaging non-motor aspects of Parkinson's disease. Prog Brain Res 2010;184:205-18
   PubMed Web of Science ®Google Scholar
• Marek K, Jennings D. Can we image premotor Parkinson disease? Neurology 2009;72(Suppl 2):S21-6
   Web of Science ®Google Scholar
• Eckert T, Tang C, Eidelberg D. Assessment of the progression of Parkinson's disease: a metabolic network approach. Lancet Neurol 2007;6:926-32
   PubMed Web of Science ®Google Scholar
• Whitwell JL, Josephs KA. Voxel-based morphometry and its application to movement disorders. Parkinsonism Relat Disord 2007;13(Suppl 3):S406-16
   PubMedGoogle Scholar
• Hotter A, Esterhammer R, Schocke MF, Potential of advanced MR imaging techniques in the differential diagnosis of parkinsonism. Mov Disord 2009;24(Suppl 2):S711-20
   Google Scholar
• Seppi K. MRI for the differential diagnosis of neurodegenerative parkinsonism in clinical practice. Parkinsonism Relat Disord 2007;13(Suppl 3):S400-5
   Google Scholar
• Wild EJ, Fox NC. Serial Volumetric MRI in Parkinsonian Disorders. Mov Disord 2009;24(Suppl 2):S691-8
   PubMedGoogle Scholar
• Pavese N, Metta V, Bose SK, Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 2010;133:3434-43
   PubMed Web of Science ®Google Scholar
• Weintraub D, Newberg AB, Cary MS, Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005;46:227-32
   PubMed Web of Science ®Google Scholar
• Sweet LH, Rao SM, Primeau M, Functional magnetic resonance imaging response to increased verbal working memory demands among patients with multiple sclerosis. Hum Brain Mapp 2006;27:28-36
   PubMed Web of Science ®Google Scholar
• Bookheimer SY, Strojwas MH, Cohen MS, Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000;343:450-6
   PubMed Web of Science ®Google Scholar
• Bondi MW, Houston WS. Eyler LT, et al. fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005;64:501-8
   PubMed Web of Science ®Google Scholar
• Janes AC, Pizzagalli DA, Richardt S, Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 2010;67:722-9. Erratum in: Biol Psychiatry 2010;67:1002
   PubMed Web of Science ®Google Scholar
• Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function and relevance to disease. Ann NY Acad Sci 2008;1124:1-38
   PubMed Web of Science ®Google Scholar
• Sweet LH, Paskavitz JF, Haley AP, Imaging phonological similarity effects on verbal working memory. Neuropsychologia 2008;46:1114-23
   PubMed Web of Science ®Google Scholar
• Sweet LH, Jerskey BA, Aloia MS. Default network response to a working memory challenge after withdrawal of continuous positive airway pressure treatment for obstructive sleep apnea. Brain Imaging Behav 2010;4:155-63
   PubMed Web of Science ®Google Scholar
• Sweet LH, Mulligan RC, Finnerty CE, Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res 2010;183:69-74
   PubMed Web of Science ®Google Scholar
• Paskavitz J, Sweet LH, Samuel J. Deactivations during Working Memory Distinguishes Multiple Sclerosis Patients from Controls. Presented at the 14th annual meeting of the Organization for Human Brain Mapping, Melbourne, Australia, 2008, Neuroimage 2008, 41:S1-5
   Google Scholar
• Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003;60:1119-24
   PubMed Web of Science ®Google Scholar
• Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-74
   PubMed Web of Science ®Google Scholar
• Zesiewicz TA, Sullivan KL, Arnulf I, Practice Parameter: treatment of non-motor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2010;74:924-31
   PubMed Web of Science ®Google Scholar
• Hardy WE. Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults. Am J Ger Pharmacother 2009;7:34-59
   PubMed Web of Science ®Google Scholar
• Parkes JD, Tarsy D, Marsden CD, Amphetamines in the treatment of Parkinson's disease. J Neuro Neurosurg Psychiatry 1975;38:232-7
   PubMed Web of Science ®Google Scholar
• Auriel E, Hausdorff JM, Giladi N. Methylphenidate for the treatment of Parkinson disease and other neurological disorders. Clin Neuropharm 2009;32:75-81
   PubMed Web of Science ®Google Scholar
• Pucci E, Branas P, D'Amico R, Amantadine for fatigue in multiple sclerosis. Cochrane Database Syst Rev 2007;CD002818
   Google Scholar
• MacAllister WS, Krupp LB. Multiple sclerosis related fatigue. Phys Med Rehabil Clin N Am 2005;16:483-502
   PubMedGoogle Scholar
• Martinez-Martin P, Catalan MJ, Benito-Leon J, Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 2006;15:597-606
   PubMed Web of Science ®Google Scholar
• Wolf E, Seppi K, Katzenschlager R, Long term anti-dyskinetic efficacy of amantadine in Parkinson's disease. Mov Disord 2010;25:1357-63
   PubMed Web of Science ®Google Scholar
• Nierenberg AA, Keefe BR, Leslie VC, Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5
   PubMed Web of Science ®Google Scholar
• Archer T, Fredriksson A, Johansson B. Exercise alleviates Parkinsonism: clinical and laboratory evidence. Acta Neurol Scand 2011;123:73-84
   PubMed Web of Science ®Google Scholar
• Elbers R, van Wegen EE, Rochester L, Is impact of fatigue an independent factor associated with physical activity in patients with idiopathic Parkinson's disease? Mov Disord 2009;24:1512-18
   PubMed Web of Science ®Google Scholar
• Persoon S, Kersten MJ, Chinapaw MJ, Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. BMC Cancer 2010;10:671
   PubMed Web of Science ®Google Scholar
• Cramp F, Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2008;2:CD006145
   Google Scholar
• Stroud NM, Minahan CL. The impact of regular physical activity on fatigue, depression and quality of life in persons with multiple sclerosis. Health Qual Life Outcomes 2009;7:68
   PubMed Web of Science ®Google Scholar
• Tench CM, McCarthy J, McCurdie I, Fatigue in systemic lupus erythematosus: a randomized controlled trial of exercise. Rheumatology (Oxford) 2003;42:1050-4
   PubMed Web of Science ®Google Scholar
• Pozehl B, Duncan K, Hertzog M. The effects of exercise training on fatigue and dyspnea in heart failure. Eur J Cardiovasc Nurs 2008;7:127-32
   PubMed Web of Science ®Google Scholar
• Edmonds M, McGuire H, Price J. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev 2004;3:CD003200
   PubMedGoogle Scholar
• Meeusen R. Exercise and the brain: insight in new therapeutic modalities. Ann Transplant 2005;10:49-51
   PubMedGoogle Scholar
• Biddle JH, Fox KR, Boutcher SH. Physical activity and psychological well-being. Routledge, London; 2000
   Google Scholar
• Aarsland D, Marsh L, Schrag A. Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009;24:2175-86
   PubMed Web of Science ®Google Scholar